SNX-1191

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameSNX-1191
Drug Alias NameHsp90 inhibitors (Serenex)SNX-1191
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHeat shock protein HSP90 inhibitors
TargetsHeat shock protein HSP90
Therapy Area/IndicationsNerve Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSerenex Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSerenex IncPfizer Inc
Active IndicationsN/A
Inactive IndicationsNerve Degeneration

Other Information

ATC CodeN/A
Related LinksN/A